NDC 0703-4502-01 - Metoclopramide

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
0703-4502
Requested NDC
0703-4502-01
Package NDCs from labels
0703-4502-01, 0703-4502-04, 0703-4502-91, 0703-4502-93, 0703-4502-81, 0703-4502-84
Manufacturer
Cardinal Health 107, LLC
Effective date
2026-09-10
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Metoclopramide - Cardinal Health 107, LLCCardinal Health 107, LLC2026-09-10HUMAN PRESCRIPTION DRUG LABEL
Metoclopramide Injection, USP Rx onlyTeva Parenteral Medicines, Inc.2026-04-22HUMAN PRESCRIPTION DRUG LABEL
Metoclopramide Injection, USP Rx onlyTeva Parenteral Medicines, Inc.2026-04-15HUMAN PRESCRIPTION DRUG LABEL
Metoclopramide - Medical Purchasing Solutions, LLCMedical Purchasing Solutions, LLC2020-01-24HUMAN PRESCRIPTION DRUG LABEL
Metoclopramide Injection USP 4502 Rx onlyTeva Parenteral Medicines, Inc.2015-05-01HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0703-4502-01Metoclopramide2 mL in 1 VIAL, SINGLE-USEINJECTION, SOLUTION214
0703-4502-04Metoclopramide25 in 1 TRAYINJECTION, SOLUTION2514
0703-4502-91Metoclopramide2 mL in 1 VIAL, SINGLE-USEINJECTION, SOLUTION28
0703-4502-93Metoclopramide10 in 1 CARTONINJECTION, SOLUTION108

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0703-4502METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.]13Current NDC, Legacy NDC, 2 package rows20230628_cccf04bd-7463-40b8-a41f-cb1093c358d7.zip
0703-4502METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.]7Current NDC, Legacy NDC, 2 package rows20240906_5645a752-8868-4b51-8b59-48bb4276d763.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0703-4502-01ML - Milliliter0703-45023c2e19db-3873-43d2-9b74-efb5910a986012014-02-04
0703-4502-04ML - Milliliter0703-4502970d311d-0e29-4d91-9b8a-561465ea9a7a12014-01-04
0703-4502-81ML - Milliliter0703-4502d8a195ab-53f6-411d-a01e-45b69b4e4f5112015-09-10
0703-4502-84ML - Milliliter0703-4502b74cc0a4-bfb8-499f-90fb-225c8939f71312015-09-10
0703-4502-91ML - Milliliter0703-4502c422a339-78a6-4e65-9e5c-d13779f4857a12015-03-03
0703-4502-93ML - Milliliter0703-45026e09e861-5b9d-4052-a6bd-5b708539b00412024-10-04
0703-4502-94ML - Milliliter0703-4502fdf9c277-d402-40d7-a220-a842ac3bfbad12015-03-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
METOCLOPRAMIDE HYDROCHLORIDEACTIVE INGREDIENTW1792A2RVDMETOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.]8
METOCLOPRAMIDEACTIVE MOIETYL4YEB44I46METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.]8
HYDROCHLORIC ACIDINACTIVE INGREDIENTQTT17582CBMETOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.]8
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8XMETOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.]8
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32IMETOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.]8
WATERINACTIVE INGREDIENT059QF0KO0RMETOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.]8
METOCLOPRAMIDE HYDROCHLORIDEACTIVE INGREDIENTW1792A2RVDMETOCLOPRAMIDE HYDROCHLORIDE INJECTION [CARDINAL HEALTH]3
METOCLOPRAMIDEACTIVE MOIETYL4YEB44I46METOCLOPRAMIDE HYDROCHLORIDE INJECTION [CARDINAL HEALTH]3
hydrochloric acidINACTIVE INGREDIENTQTT17582CBMETOCLOPRAMIDE HYDROCHLORIDE INJECTION [CARDINAL HEALTH]3
Sodium ChlorideINACTIVE INGREDIENT451W47IQ8XMETOCLOPRAMIDE HYDROCHLORIDE INJECTION [CARDINAL HEALTH]3
sodium hydroxideINACTIVE INGREDIENT55X04QC32IMETOCLOPRAMIDE HYDROCHLORIDE INJECTION [CARDINAL HEALTH]3
WaterINACTIVE INGREDIENT059QF0KO0RMETOCLOPRAMIDE HYDROCHLORIDE INJECTION [CARDINAL HEALTH]3
METOCLOPRAMIDE HYDROCHLORIDEACTIVE INGREDIENTW1792A2RVDMETOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.]1
METOCLOPRAMIDE HYDROCHLORIDEACTIVE INGREDIENTW1792A2RVDMETOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.]1
METOCLOPRAMIDEACTIVE MOIETYL4YEB44I46METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.]1
METOCLOPRAMIDEACTIVE MOIETYL4YEB44I46METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.]1
HYDROCHLORIC ACIDINACTIVE INGREDIENTQTT17582CBMETOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.]1
HYDROCHLORIC ACIDINACTIVE INGREDIENTQTT17582CBMETOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.]1
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8XMETOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.]1
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8XMETOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.]1
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32IMETOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.]1
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32IMETOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.]1
WATERINACTIVE INGREDIENT059QF0KO0RMETOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.]1
WATERINACTIVE INGREDIENT059QF0KO0RMETOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.]1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 53 of 53 · 1,041 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Lactated RingersSODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDEBaxter Healthcare Corporationf09f80bf-2f8b-4420-865d-aec2d5e5cd4d2012-06-12Exact identifier
unii: 451W47IQ8X

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.